REFRACTORY CHRONIC COUGH
Clinical trials for REFRACTORY CHRONIC COUGH explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY CHRONIC COUGH trials appear
Sign up with your email to follow new studies for REFRACTORY CHRONIC COUGH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for hacking cough: new pill shows promise in clinical trial
Symptom relief CompletedThis study tested a new tablet called nalbuphine ER for people with a long-lasting cough that doesn't get better with treatment. 66 adults with refractory chronic cough took the drug or a placebo to see if it reduced coughing. The goal was to measure cough frequency and check for…
Matched conditions: REFRACTORY CHRONIC COUGH
Phase: PHASE2 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
New pill aims to silence stubborn cough
Symptom relief CompletedThis study tested an experimental drug called HRS-2261 in 97 adults with refractory chronic cough (a cough lasting over a year that doesn't respond to usual treatments). Participants received either the drug or a placebo for 4 weeks. The main goal was to see if the drug reduces c…
Matched conditions: REFRACTORY CHRONIC COUGH
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC